Incyte Corp grants equity awards to EVP of HR

Incyte Corp EVP, Human Resources Ramitpal K. Basi received multiple equity awards.

Rhea-AI Filing Summary

Incyte Corp EVP, Human Resources Ramitpal K. Basi received multiple equity awards. On July 16, 2026, he was granted 4,991 restricted stock units vesting 25% annually over four years, 21,548 employee stock options with a $116.65 exercise price vesting over four years, and 12,479 performance shares that may deliver up to 200% of one share each based on relative total shareholder return over a three-year period. In total, 11,497 shares of common stock are issuable upon vesting of his outstanding restricted stock units.

Insider Trade Summary

Grant/Award: 39,018 shares

Grant/Award 3 txns

Insider Basi Ramitpal K

Role EVP, Human Resources

Type	Security	Shares	Price	Value
Grant/Award	Performance Shares F3	12,479	$0.00	$0.00
Grant/Award	Employee Stock Option (right to buy) F4	21,548	$0.00	$0.00
Grant/Award	Common Stock F1, F2	4,991	$0.00	$0.00

Holdings After Transaction: Performance Shares — 12,479 contracts (Direct); Employee Stock Option (right to buy) — 21,548 contracts (Direct); Common Stock — 11,497 shares (Direct)

Footnotes (4)

1. F1. Represents award of restricted stock units ("RSUs") that will vest 25% annually over four years. The RSUs may be settled only for shares of common stock on a one-for-one basis.
2. F2. Including the July 16, 2026 grant, this includes an aggregate of 11,497 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested.
3. F3. Each performance share represents the right to receive up to 200% of one share of common stock. Such shares may be earned based upon the issuer's relative total shareholder return ("TSR") over a three-year performance period beginning on January 1, 2026 as compared to the TSR of companies in a fixed peer group, as set forth in the Performance Share Award Agreement. The earned shares will vest on the third anniversary of the grant date subject to the Reporting Person's continued service with the issuer.
4. F4. The July 16, 2026 options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years. Remarks:

Key Figures

RSUs granted: 4,991 shares Stock options granted: 21,548 options Option exercise price: $116.65 per share +4 more

7 metrics

RSUs granted 4,991 shares Restricted stock units granted on July 16, 2026; vest 25% annually over four years.

Stock options granted 21,548 options Employee stock options granted on July 16, 2026 with $116.65 exercise price, expiring July 15, 2036.

Option exercise price $116.65 per share Exercise price for the July 16, 2026 employee stock option grant.

Performance shares granted 12,479 units Performance shares granted July 16, 2026; each may deliver up to 200% of one share based on TSR.

RSU shares issuable 11,497 shares Common shares issuable from outstanding unvested restricted stock units held after the July 16, 2026 grant.

Performance period start January 1, 2026 Beginning of the three-year relative total shareholder return period for performance shares.

Option expiration date July 15, 2036 Expiration date of the employee stock options granted on July 16, 2026.

Key Terms

restricted stock units ("RSUs"), Performance Shares, relative total shareholder return ("TSR"), fixed peer group, +1 more

5 terms

restricted stock units ("RSUs") financial

"Represents award of restricted stock units ("RSUs") that will vest 25% annually"

Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.

Performance Shares financial

"Each performance share represents the right to receive up to 200% of one share"

Performance shares are a type of company stock given to executives or employees that only become theirs if the company meets specific goals, like hitting certain profits or growth targets. They motivate leaders to work toward the company’s success, because their additional shares depend on achieving these results.

relative total shareholder return ("TSR") financial

"earned based upon the issuer's relative total shareholder return ("TSR") over a three-year"

fixed peer group financial

"as compared to the TSR of companies in a fixed peer group, as set forth"

Performance Share Award Agreement financial

"as set forth in the Performance Share Award Agreement. The earned shares"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What equity awards did Incyte (INCY) grant to EVP Ramitpal K. Basi on July 16, 2026?

Incyte granted Basi 4,991 RSUs, 21,548 employee stock options, and 12,479 performance shares on July 16, 2026. RSUs and options vest over four years, while performance shares depend on three-year relative TSR and vest on the third anniversary of grant.

How many restricted stock units did Ramitpal K. Basi receive from Incyte (INCY) and how do they vest?

Basi received 4,991 restricted stock units that vest 25% annually over four years. These RSUs settle only in common stock on a one-for-one basis, contributing to a total of 11,497 shares issuable from his outstanding unvested RSU awards.

What are the terms of Ramitpal K. Basi’s new Incyte (INCY) stock options?

Basi was granted 21,548 employee stock options with a $116.65 exercise price, expiring on July 15, 2036. The options vest in 37 installments: 25% after one year, with the remaining 75% vesting monthly over the following three years.

How do Incyte (INCY) performance shares granted to Ramitpal K. Basi work?

He received 12,479 performance shares, each representing the right to receive up to 200% of one share of common stock. Shares are earned based on three-year relative TSR versus a fixed peer group and vest on the third anniversary of grant, subject to continued service.

What is the total number of Incyte (INCY) shares underlying Ramitpal K. Basi’s unvested RSUs?

Including the July 16, 2026 grant, Basi has 11,497 shares of Incyte common stock issuable under previously reported restricted stock units that have not vested. This figure reflects only unvested RSU-based share rights, not his total equity holdings.

Were Ramitpal K. Basi’s Incyte (INCY) equity transactions made under a Rule 10b5-1 trading plan?

The disclosure indicates no Rule 10b5-1 trading plan for these transactions. All reported awards on July 16, 2026 are compensation-related grants and not sales or purchases executed under a pre-arranged trading program.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/20/2026 - 04:08 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Basi Ramitpal K

(Last) (First) (Middle)

1801 AUGUSTINE CUT-OFF

(Street)

WILMINGTON DELAWARE 19803

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
INCYTE CORP [ INCY ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP, Human Resources

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/16/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/16/2026		A		4,991(1)	A	$0	11,497(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Performance Shares	(3)	07/16/2026		A		12,479		(3)	07/16/2029	Common Stock	12,479	$0	12,479	D
Employee Stock Option (right to buy)	$116.65	07/16/2026		A		21,548		(4)	07/15/2036	Common Stock	21,548	$0	21,548	D

Explanation of Responses:

1. Represents award of restricted stock units ("RSUs") that will vest 25% annually over four years. The RSUs may be settled only for shares of common stock on a one-for-one basis.

2. Including the July 16, 2026 grant, this includes an aggregate of 11,497 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested.

3. Each performance share represents the right to receive up to 200% of one share of common stock. Such shares may be earned based upon the issuer's relative total shareholder return ("TSR") over a three-year performance period beginning on January 1, 2026 as compared to the TSR of companies in a fixed peer group, as set forth in the Performance Share Award Agreement. The earned shares will vest on the third anniversary of the grant date subject to the Reporting Person's continued service with the issuer.

4. The July 16, 2026 options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years. Remarks:

Remarks:

	/s/ Elizabeth Feeney, Attorney-In-Fact	07/20/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)